Preeclampsia (PE) is a serious pregnancy complication, affecting about 5–7% of
pregnancies worldwide and is characterized by hypertension and damage to multiple …

Preeclampsia is a common pregnancy complication, affecting 2% to 8% of pregnancies
worldwide, and is an important cause of both maternal and fetal morbidity and mortality …

A healthy pregnancy outcome depends on the activation of the renin-angiotensin-
aldosterone system (RAAS) as a regulated, integrated response to the growing demands of …

Abstract Purpose of Review Preeclampsia affects 3–4% of pregnancies with few treatment
options to reduce maternal and fetal harm. Recent evidence that targeting the complement …

Elevated blood pressure (BP), or hypertension, is the main risk factor for cardiovascular
disease. As a multifactorial and systemic disease that involves multiple organs and systems …

The placenta is an essential organ that is formed during pregnancy and its proper
development is critical for embryonic survival. While several animal models have been …

Copeptin, a marker of arginine vasopressin (AVP) secretion, is elevated throughout human
pregnancies complicated by preeclampsia (PE), and AVP infusion throughout gestation is …

Aims: Although preeclampsia (PE) has been attributed to excessive oxidative stress (OS) in
the placenta, mild antioxidants failed to prevent PE in clinical trials. As mitochondria are a …

Hypertensive disorders of pregnancy such as preeclampsia, eclampsia, superimposed
preeclampsia, and gestational hypertension are major causes of fetal and maternal …

The use of nanoparticles (NPs) to deliver therapeutics to reproductive organs is an emerging
approach to safely and effectively treat mothers and babies facing pregnancy complications …